Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 30,400 shares, a drop of 61.4% from the November 15th total of 78,800 shares. Based on an average trading volume of 1,400,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 7.5% of the shares of the stock are sold short.

Avalon GloboCare Price Performance

Shares of NASDAQ ALBT traded up $0.74 during mid-day trading on Wednesday, reaching $4.93. The company’s stock had a trading volume of 356,656 shares, compared to its average volume of 513,735. Avalon GloboCare has a 52 week low of $2.11 and a 52 week high of $21.60. The stock has a fifty day moving average of $3.08 and a two-hundred day moving average of $4.74. The firm has a market capitalization of $5.39 million, a PE ratio of -0.23 and a beta of 0.27.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.